Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
Clinical Evidence Human Trials: A randomized, placebo-controlled study in obese adults demonstrated that AOD-9604 significantly reduced abdominal and total body fat over several weeks of treatment, without serious side effects Animal Studies: Preclinical studies in mice and rats showed that AOD-9604: Stimulated lipolysis Inhibited lipogenesis (formation of new fat) Prevented weight gain despite high-fat diets This dual actionenhancing fat breakdown and inhibiting fat formationpositions AOD-9604 as a potent tool for combating obesity
Administration, Storage, and Practical Considerations In research contexts, GHK-Cu is typically administered as a subcutaneous or topical preparation
This way, whenever a dose is extracted from the vial, the stopper will not self-seal effectively, leading to an increased risk of contamination due to environmental influence
Many patients report feeling more energized and refreshed soon after their session
